000 01508 a2200433 4500
005 20250517093035.0
264 0 _c20180202
008 201802s 0 0 eng d
022 _a2040-2058
024 7 _a10.3851/IMP3053
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAndré-Garnier, Elisabeth
245 0 0 _aEmergence of HCV resistance-associated variants in patients failing sofosbuvir-based regimens: an observational cohort.
_h[electronic resource]
260 _bAntiviral therapy
_c2016
300 _a611-619 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aCohort Studies
650 0 4 _aDrug Resistance, Viral
_xgenetics
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aSofosbuvir
_xtherapeutic use
650 0 4 _aTreatment Failure
650 0 4 _aViral Nonstructural Proteins
_xantagonists & inhibitors
700 1 _aRibeyrol, Olivier
700 1 _aGournay, Jerome
700 1 _aBesse, Bernard
700 1 _aCoste-Burel, Marianne
700 1 _aMabille-Archambeaud, Isabelle
700 1 _aBillaud, Eric
700 1 _aBiron, Charlotte
700 1 _aPineau, Solene
700 1 _aRaffi, François
700 1 _aImbert-Marcille, Berthe-Marie
773 0 _tAntiviral therapy
_gvol. 21
_gno. 7
_gp. 611-619
856 4 0 _uhttps://doi.org/10.3851/IMP3053
_zAvailable from publisher's website
999 _c25971612
_d25971612